Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioTech Medics acquires FHJ patents
The patents cover FHJ Scientific’s proprietary SHBAN compound solution. Scientific evidence and studies by top medical institutions suggest the unique solution may be used in a variety of
The patents cover FHJ Scientific’s proprietary SHBAN compound solution. Scientific evidence and studies by top medical institutions suggest the unique solution may be used in a variety of
The WHO filings take the number of Ranbaxy anti-retrovirals (ARVs) submitted to the authority to five, while the FDA filing, which has been submitted under the FDA’s expedited
The milestone is based on Wyeth and Curis’ continued progress in preclinical development of hedgehog pathway agonists for the treatment of stroke, neurological and other disorders. The milestone
Gabapentin is the AB-rated generic equivalent of Neurontin, a drug used to treat epileptic seizures which is marketed by Warner-Lambert, a unit of Pfizer. On February 11, 2005,
Initial in vitro study results have indicated that PPL-100, a phosphorylated pro-drug of PL-100, is 1,000-fold more water soluble than its precursor. More importantly, pharmacokinetics studies conducted in
The meeting between Protein Design Labs (PDL) and the FDA was to discuss the future development pathway for PDL’s Nuvion (visilizumab) humanized anti-CD3 antibody being developed for the
Under the terms of the agreement, Pharmacopeia is employing its comprehensive, integrated drug discovery platform and discovery expertise that has, to date, resulted in four programs advancing into
Under the terms of the agreement, which is contingent upon completion of the sale of Savient’s global biologics manufacturing business to Ferring BV and Ferring International Centre SA,
Impavido (miltefosine) has been approved to treat the cutaneous form of leishmaniasis, a severe parasitic skin disease estimated to affect millions of people worldwide. This is the first-ever
This achievement solidifies Schering-Plough Corporation’s long-standing leadership position of successfully converting prescription products into major over-the-counter (OTC) brands, as a core marketing strategy for extending the lifecycle of